4 terminated. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Terminated 4 |
Follow Growth Hormone Deficiency: new trials by email Literature Review of Growth Hormone Deficiency trials Research Report on Growth Hormone Deficiency
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Long-Term Safety Study of Somavaratan in Japanese Children With Growth Hormone Deficiency Somavaratan - Growth Hormone Deficiency | Phase 3 | Terminated | Versartis Inc. | 21 | 2017-03-31 | 2018-03-09 |
| Study of TV-1106 in Growth Hormone-Deficient Adults TV-1106, Placebo - Growth Hormone Deficiency | Phase 3 | Terminated | Teva Branded Pharmaceutical Products R&D, Inc. | 14 | 2015-04-30 | 2022-01-24 |
| Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD) TV-1106, dGH - Growth Hormone Deficiency | Phase 3 | Terminated | Teva Branded Pharmaceutical Products R&D, Inc. | 34 | 2015-04-30 | 2021-12-10 |
| Efficacy of Somatropin in Adult Patients With Isolated Growth Hormone Deficiency Placebo, Somatropin - Growth Hormone Deficiency | Phase 3 | Terminated | Pfizer | 9 | 2008-05-01 | 2013-03-04 |
Bone Diseases (4) · Bone Diseases, Developmental (4) · Bone Diseases, Endocrine (4) · Brain Diseases (4) · Central Nervous System Diseases (4) · Dwarfism (4) · Endocrine System Diseases (4) · Hypopituitarism (4) · Hypothalamic Diseases (4) · Musculoskeletal Diseases (4) · Nervous System Diseases (4) · Pituitary Diseases (4)
Human Growth Hormone (2) · albusomatropin (2)
Teva Branded Pharmaceutical Products R&D, Inc. (2) · Pfizer (1) · Versartis Inc. (1)
United States (3) · Austria (2) · Czechia (2) · Greece (2) · Hungary (2) · Italy (2) · Germany (1) · Russia (1) · Slovakia (1) · Spain (1)
2014 (1)